Vor Biopharma Inc. (VOR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -38.25M | -22.8M | -53.66M | -35.18M | -31.07M | -24.06M | -23.29M | -21.85M | -30.46M | -24.03M | -27.9M | -24.1M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -23.11% | 5.24% | -130.46% | -61.05% | -1.97% | -0.15% | 16.54% | 9.35% | -25.54% | -30.96% | -47.59% | 3.57% |
| Net Income | -219.59M | 1.72B | -812.68M | -1.57B | -32.49M | -30.71M | -27.56M | -27.84M | -30.8M | -26.26M | -33.19M | -29.98M |
| Depreciation & Amortization | 28K | -40K | 2K | 2.1M | 825K | 865K | 820K | 869K | 943K | 892K | -1.42M | 870K |
| Stock-Based Compensation | 0 | 8.95M | 8.03M | 0 | 1.93M | 1.71M | 2.26M | 2.79M | 3.08M | 1.89M | 3.16M | 4.24M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.45M | 0 |
| Other Non-Cash Items | 196.85M | -1.76B | 745.93M | 1.53B | 1.3M | 1.26M | 1.29M | 922K | 435K | 228K | -3.16M | -67K |
| Working Capital Changes | -15.54M | 3.16M | 5.06M | 4.63M | -2.64M | 2.82M | -99K | 1.41M | -4.12M | -779K | 1.27M | 838K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -9.1M | 6.21M | 5M | 1.1M | -1.37M | 0 | 485K | 551K | -2.48M | 0 | 2.66M | 0 |
| Cash from Investing | -263.24M | -48.97M | -244K | 646K | -230K | -72K | -34K | 52.99M | 43.97M | 10.34M | 40.54M | 13.64M |
| Capital Expenditures | -48K | -314K | -244K | -152K | -231K | -72K | -34K | -9K | -114K | -111K | -465K | -399K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | -799K | 0 | 799K | 0 | 0 | 0 | 0 | 0 | 0 | -41K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 799K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41K | 0 |
| Cash from Financing | 74.87M | 307.8M | 21.55M | 175.06M | -606K | 53.29M | 41K | -31K | 96K | 25K | 176K | 218K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 74.87M | 307.93M | 21.57M | 175.1M | -551K | 55.53M | 111K | 20K | 278K | -15K | 392K | 579K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -2K | -131K | -19K | -32K | -55K | -2.24M | -70K | -51K | -182K | 40K | -216K | -361K |
| Net Change in Cash | -226.61M | 236.19M | -32.52M | 142.94M | -31.9M | 29.15M | -23.28M | 31.11M | 13.6M | -13.67M | 12.81M | -10.24M |
| Free Cash Flow | -38.29M | -23.11M | -53.91M | -35.34M | -31.3M | -24.14M | -23.32M | -21.86M | -30.58M | -24.14M | -28.36M | -24.5M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -22.36% | 4.23% | -131.17% | -61.68% | -2.35% | 0.01% | 17.78% | 10.79% | -25.52% | -29.3% | -47.72% | 20.52% |
| FCF per Share | -89.03 | -2.34 | -8.07 | -5.64 | -5.01 | -7.03 | -6.81 | -6.40 | -8.99 | -7.11 | -8.39 | -7.31 |
| FCF Conversion (FCF/Net Income) | 0.17x | -0.01x | 0.07x | 0.02x | 0.96x | 0.78x | 0.84x | 0.78x | 0.99x | 0.91x | 0.84x | 0.80x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |